Cited by 15Antimicrobial Resistance in StaphylococcusStreptococcal Infections and TreatmentsAntibiotic Use and Resistance

Study of susceptibility to antibiotics and molecular characterization of high virulence Staphylococcus aureus strains isolated from a rural hospital in Ethiopia

Open access
Verdú-Expósito, Cristina, Romanyk, Juan, Cuadros-González, Juan, TesfaMariam, Abraham, Copa-Patiño, José Luis, Pérez-Serrano, Jorge, Soliveri, Juan·2020·PLOS ONE

Abstract

We characterised 80 Staphylococcus aureus strains isolated from human patients with SSTIs at a rural hospital in Ethiopia. Susceptibility to antibiotic of all strains was tested. The MLST method was used to type and a phylogenetic analysis was conducted employing the sequences of 7 housekeeping genes. PCR amplification was used to investigate the presence of the following virulence genes in all strains: hla (α-haemolysin), tstH (toxic shock syndrome toxin), luk PV (Panton-Valentine leukocidin), fnbA (fibronectin binding protein A) and mecA (methicillin resistance). Most of the strains were resistant to penicillin and ampicillin, but only 3 strains were resistant to oxacillin, and 1 of them was a true MRSA. The MLST results showed a high diversity of sequence types (ST), 55% of which were new, and ST152 was the most prevalent. A phylogeny study showed that many of the new STs were phylogenetically related to other previously described STs, but bore little relationship to the only ST from Ethiopia described in the database. Virulence gene detection showed a high prevalence of strains encoding the hla, fnbA and pvl genes (98.77%, 96.3% and 72.84%, respectively), a low prevalence of the tst gene (13.58%) and a markedly low prevalence of MRSA (1.25%). S. aureus strains isolated from patients in a rural area in Ethiopia showed low levels of antibiotic resistance, except to penicillin. Moreover, this study reveals new STs in Eastern Africa that are phylogenetically related to other previously described STs, and confirm the high prevalence of the pvl gene and the low prevalence of MRSA on the continent.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0230031

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The most prevalent MRSA genotypes in SSA have been demonstrated to be ST5, ST8, ST15, ST88, ST152, ST241, and ST239.

    “Moreover, the most prevalent genotypes have been demonstrated to be ST5, ST8, ST15, ST88, ST152, ST241, and ST239.162,[169][170][171]”

    From Antimicrobial Resistance Rates and Surveillance in Sub-Saharan Africa: Where Are We Now? (2022) · cites this paper as [162]

    The Results (Strain typing by MLST; page unavailable) identify ST152 as the most prevalent sequence type in this Ethiopian S. aureus sample and also report ST5 and ST15. The Discussion (page unavailable) cites an African review naming ST30, ST121 and ST152 as prevalent S. aureus types, explicitly describing those isolates as MSSA. Neither passage establishes the claimed seven-type list as the most prevalent MRSA genotypes across sub-Saharan Africa. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 57

  1. J. P. Steinberg, 2011, Nosocomial and Community-Acquired Staphylococcus aureus bacteremias from 1980 to 1993: impact of intravascular devices and methicillin resistance, Clinical Infectious Diseases, 23, 255, 10.1093/clinids/23.2.255 · DOI
  2. A.K. Ziebandt, 2010, Proteomics uncovers extreme heterogeneity in the Staphylococcus aureus exoproteome due to genomic plasticity and variant gene regulation, Proeomics, 10, 1634, 10.1002/pmic.200900313 · DOI
  3. J M. Musser, 1992, Clonal analysis of methicillin-resistant Staphylococcus aureus strains from intercontinental sources: association of the mec gene with divergent phylogenetic lineages implies dissemination by horizontal transfer and recombination, Journal of Clinical Microbiology, 30, 2058, 10.1128/JCM.30.8.2058-2063.1992 · DOI
  4. M E. Stryjewski, 2014, Methicillin-resistant Staphylococcus aureus: An evolving pathogen, Clinical Infectious Diseases, 58, 10, 10.1093/cid/cit613 · DOI · Paper page
  5. R. R. Filipe, 2001, Complementation of the essential peptidoglycan transpeptidase function of penicillin-binding protein 2 (PBP2) by the drug resistance protein PBP2A in Staphylococcus aureus, Journal of Bacteriology, 183, 6525, 10.1128/JB.183.22.6525-6531.2001 · DOI
  6. D Lim, 2002, Structural basis for the β lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus, Nature Structural Biology, 9, 870
  7. T Ito, 1998, Acquisiton of methicillin resistance and progression of multiantibiotic resistance in Methicillin-Resistant Staphylococcus aureus, Yonsei Medical Journal, 39, 526, 10.3349/ymj.1998.39.6.526 · DOI
  8. F. R. Deleo, 2010, Community-associated methicillin-resistant Staphylococcus aureus, Lancet, 375, 1557, 10.1016/S0140-6736(09)61999-1 · DOI
  9. T Kejela, 2013, Prevalence and antibiotic susceptibility pattern of methicillin-resistant Staphylococcus aureus (MRSA) among primary school children and prisoners in Jimma Town, Southwest Ethiopia, Annals of Clinical Microbiology and Antimicrobials, 12, 11, 10.1186/1476-0711-12-11 · DOI
  10. S. M. Abdulgader, 2015, ,Molecular epidemiology of Methicillin-resistant Staphylococcus aureus in Africa: A systematic review, Frontiers in Microbiology, 6, 348, 10.3389/fmicb.2015.00348 · DOI
  11. S Eshetie, 2016, Methicillin resistant Staphylococcus aureus in Ethiopia: A meta-analysis, BMC Infectious Diseases, 16, 689, 10.1186/s12879-016-2014-0 · DOI
  12. P Couppie, 1994, Leukocidin from Staphylococcus aureus and cutaneous infections: an epidemiologic study, Archives of Dermatology, 130, 1208, 10.1001/archderm.130.9.1208 · DOI
  13. J Etienne, 2005, Panton-Valentine Leukocidin: a marker of severity for Staphylococcus aureus infection?, Clinical Infectious Diseases, 41, 591, 10.1086/432481 · DOI
  14. M Labandeira-Rey, 2007, Staphylococcus aureus Panton-Valentine Leukocidin causes necrotizing pneumonia, Science, 315, 1130, 10.1126/science.1137165 · DOI
  15. F. Schaumburg, 2014, New epidemiology of Staphylococcus aureus infection in Africa, Clinical Microbiology and Infection, 20, 589, 10.1111/1469-0691.12690 · DOI
  16. B. Hassel, 2015, Staphylococcal α-hemolysin is neurotoxic and causes lysis of brain cells in vivo and in vitro, NeuroToxicology, 48, 61, 10.1016/j.neuro.2015.03.001 · DOI
  17. B. J. Berube, 2014, The psmα locus regulates production of Staphylococcus aureus alpha-toxin during infection, Infection and Immunity, 82, 3350, 10.1128/IAI.00089-14 · DOI
  18. A Tavares, 2014, Insights into Alpha-Hemolysin (Hla) evolution and expression among Staphylococcus aureus clones with hospital and community origin, PLoS ONE, 9, e98634, 10.1371/journal.pone.0098634 · DOI
  19. K Plata, 2009, Rosato A. E. & Wegrzyn G. Staphylococcus aureus as an infectious agent: Overview of biochemistry and molecular genetics of its pathogenicity, Acta Biochimica Polonica, 56, 597, 10.18388/abp.2009_2491 · DOI
  20. M Zschöck, 2000, Detection of genes for enterotoxins (ent) and toxic shock syndrome toxin-1 (tst) in mammary isolates of Staphylococcus aureus by polymerase-chain-reaction, International Dairy Journal, 10, 569, 10.1016/S0958-6946(00)00084-4 · DOI
  21. S Takeuchi, 1998, Production of toxic shock syndrome toxin by Staphylococcus aureus isolated from mastitic cow’s milk and farm bulk milk, Veterinary Microbiology, 59, 251, 10.1016/S0378-1135(96)01253-9 · DOI
  22. J. M. Fueyo, 2005, Enterotoxins and toxic shock syndrome toxin in Staphylococcus aureus recovered from human nasal carriers and manually handled foods: Epidemiological and genetic findings, Microbes and Infection, 7, 187, 10.1016/j.micinf.2004.10.009 · DOI
  23. P Kuusela, 1978, Fibronectin binds to Staphylococcus aureus, Nature, 276, 718, 10.1038/276718a0 · DOI
  24. A Woods, 1986, Adhesion and cytoskeletal organisation of fibroblasts in response to fibronectin fragments, The EMBO Journal, 5, 665, 10.1002/j.1460-2075.1986.tb04265.x · DOI
  25. S. J. Peacock, 2000, ,Clinical isolates of Staphylococcus aureus exhibit diversity in fnb genes and adhesion to human fibronectin, Journal of Infection, 41, 23, 10.1053/jinf.2000.0657 · DOI
  26. A Shibabaw, 2014, Antimicrobial susceptibility pattern of nasal Staphylococcus aureus among Dessie Referral Hospital health care workers, Dessie, Northeast Ethiopia. International Journal of Infectious Diseases, 25, 22, 10.1016/j.ijid.2014.03.1386 · DOI
  27. S Delgado, 2011, Characterization of Staphylococcus aureus strains involved in human and bovine mastitis, FEMS Immunology and Medical Microbiology, 62, 225, 10.1111/j.1574-695X.2011.00806.x · DOI
  28. K Zhang, 2005, Novel Multiplex PCR assay for characterization and concomitant subtyping of Staphylococcal Cassette Chromosome mec types I to V in Methicillin-Resistant Staphylococcus aureus, Journal of Clinical Microbiology, 43, 5026, 10.1128/JCM.43.10.5026-5033.2005 · DOI
  29. I Massova, 1998, &Kinship and diversification of bacterial penicillin-binding proteins and β-lactamases, Antimicrobial Agents and Chemotherapy, 42, 1, 10.1128/AAC.42.1.1 · DOI
  30. T Dilnessa, 2016, Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus isolated from clinical samples at Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia, BMC Infectious Diseases, 16, 1
  31. F.M. Wagenlehner, 2011, National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients, Urologe Ausgabe A, 50, 153
  32. B Abera, 2008, Methicillin-resistant strains of Staphylococcus aureus and coagulase- negative staphylococus from clinical isolates at Felege Hiwot Refferal Hospital, North West Ethiopia. Ethiopian Medical Journal, 46, 149
  33. J. P. Horcajada, 2014, Ceftarolina, un nuevo antimicrobiano de amplio espectro en la era de las multirresistencias, Enfermedades Infecciosas y Microbiología Clínica, 32, 1, 10.1016/S0213-005X(14)70151-X · DOI
  34. B. T. Tadesse, 2017, Antimicrobial resistance in Africa: A systematic review, BMC Infectious Diseases, 17, 1, 10.1186/s12879-017-2713-1 · DOI
  35. C Lozano, 2012, Genetic environment and location of the lnu(A) and lnu(B) genes in methicillin-resistant Staphylococcus aureus and other staphylococci of animal and human origin, Journal of Antimicrobial Chemotherapy, 67, 2804, 10.1093/jac/dks320 · DOI
  36. L Li, 2015, Macrolide-lincosamide-streptogramin resistance phenotypes and genotypes of coagulase-positive Staphylococcus aureus and coagulase-negative staphylococcal isolates from bovine mastitis, BMC Veterinary Research, 11, 1
  37. D Nurjadi, 2015, Predominance of dfrG as determinant of trimethoprim resistance in imported Staphylococcus aureus, Clinical Microbiology and Infection, 21, 1095.e5, 10.1016/j.cmi.2015.08.021 · DOI
  38. J. A. Lindsay, 2004, Staphylococcus aureus: superbug, super genome?, Trends in Microbiology, 12, 378, 10.1016/j.tim.2004.06.004 · DOI
  39. M. C. Enright, 1999, Multilocus sequence typing, Trends in Microbiology, 7, 482, 10.1016/S0966-842X(99)01609-1 · DOI
  40. E.J. Feil, 2003, How clonal is Staphylococcus aureus?, Journal of Bacteriology, 185, 3307, 10.1128/JB.185.11.3307-3316.2003 · DOI
  41. W.B. van Leeuwen, 2003, Multilocus Sequence Typing of Staphylococcus aureus with DNA Array Technology, Journal of Clinical Microbiology, 41, 3323, 10.1128/JCM.41.7.3323-3326.2003 · DOI
  42. B Cribier, 1992, Staphylococcus aureus Leukodicin: a new virulence factor in cutaneous infections?, Dermatology, 185, 175, 10.1159/000247443 · DOI
  43. G Lina, 1999, Involvement of Panton-Valentine Leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia, Clinical Infectious Diseases, 29, 1128, 10.1086/313461 · DOI · Paper page
  44. S Breurec, 2010, Working Group on Staphylococcus aureus Infections, Garin B., Laurent F. Epidemiology of methicillin-susceptible Staphylococcus aureus lineages in five major African towns: high prevalence of Panton–Valentine leukocidin genes, Clinical Microbiology and Infection, 17, 633, 10.1111/j.1469-0691.2010.03320.x · DOI
  45. R Ruimy, 2008, The carriage population of Staphylococcus aureus from Mali is composed of a combination of pandemic clones and the divergent Panton-Valentine Leukocidin-positive, Journal of Bacteriology, 190, 3962, 10.1128/JB.01947-07 · DOI
  46. J.-P. Rasigade, 2014, New epidemiology of Staphylococcus aureus infections in the Middle East, Clinical Microbiology and Infection, 20, 587, 10.1111/1469-0691.12718 · DOI
  47. P Zanger, 2012, mport and spread of Panton-Valentine Leukocidin–Positive Staphylococcus aureus through nasal carriage and skin infections in travelers returning from the Tropics and Subtropics, Clinical Infectious Diseases, 54, 483, 10.1093/cid/cir822 · DOI
  48. N.A. Amissah, 2017, Virulence potential of Staphylococcus aureus isolates from Buruli ulcer patients, International Journal of Medical Microbiology, 307, 223, 10.1016/j.ijmm.2017.04.002 · DOI
  49. D.P. Kateete, 2011, High prevalence of methicillin resistant Staphylococcus aureus in the surgical units of Mulago hospital in Kampala, Uganda, BMC Research Notes, 4, 326, 10.1186/1756-0500-4-326 · DOI
  50. D.E. Tabor, 2016, Staphylococcus aureus alpha-toxin Is conserved among diverse hospital respiratory isolates collected from a global surveillance study and is neutralized by monoclonal antibody MEDI4893, Antimicrobial Agents and Chemotherapy, 60, 5312, 10.1128/AAC.00357-16 · DOI
  51. W. F. Oosthuysen, 2014, In vitro characterization of representative clinical South African Staphylococcus aureus isolates from various clonal lineages, New Microbes and New Infections, 2, 115, 10.1002/nmi2.53 · DOI
  52. D Vubil, 2017, Molecular characterization of Community Acquired Staphylococcus aureus bacteremia in young children in Southern Mozambique, 2001–2009, Frontiers in Microbiology, 8, 1
  53. H De Boeck, 2015, Staphylococcus aureus nasal carriage among healthcare workers in Kisangani, the Democratic Republic of the Congo, European Journal of Clinical Microbiology Infectious Diseases, 34, 1567, 10.1007/s10096-015-2387-9 · DOI
  54. K Becker, 2003, Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens, Journal of Clinical Investigation, 41, 1434
  55. Paediatric Infectious Disease Group Switzerland Staphylococcus aureus Study Group, 2010, Molecular epidemiology of the nasal colonization by methicillin susceptible Staphylococcus aureus in Swiss children, Clinical Microbiology and Infection, 16, 1414, 10.1111/j.1469-0691.2009.03090.x · DOI
  56. A. S. Devries, 2011, ,Staphylococcal toxic shock syndrome 2000–2006: epidemiology, clinical features, and molecular characteristics, PLoS Medicine, 6
  57. R. A. Hajjeh, 1999, Toxic Shock Syndrome in the United States: Surveillance Update, 1979–1966, Emerging Infectious Diseases, 5, 807, 10.3201/eid0506.990611 · DOI

Cited by

Sorted by citations

Authors
Verdú-Expósito, C., Romanyk, J., Cuadros-González, J., TesfaMariam, A., Copa-Patiño, J. L., Pérez-Serrano, J., & Soliveri, J.
Affiliations
  • Universidad de Alcalá (ES)
  • Hospital Universitario Príncipe de Asturias (ES)
Corresponding author
Verdú-Expósito, Cristina
Venue
PLOS ONE
Published
2020-03-12
Volume
15
Issue
3
Pages
e0230031
ISSN
1932-6203 (ISSN-L)
OpenAlex
W3011108251
Cited by
15
References
1
Citations by year
2026: 2 · 2025: 1 · 2024: 2 · 2023: 4 · 2022: 3 · 2021: 2 · 2020: 1
FWCI
0.33
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
Keywords
Staphylococcus aureus, antibiotic susceptibility, methicillin resistance, virulence genes, Panton-Valentine leukocidin, alpha-hemolysin, toxic shock syndrome toxin, fibronectin-binding protein A, sequence types, molecular epidemiology, penicillin resistance, ampicillin resistance, oxacillin resistance, skin and soft tissue infections, rural hospitals, Ethiopia, new sequence types
MeSH terms
Ceftaroline, Anti-Bacterial Agents, Bacterial Proteins, Bacterial Toxins, Cephalosporins, Ethiopia, Exotoxins, Hospitals, Rural, Humans, Leukocidins, Microbial Sensitivity Tests, Penicillins, Phylogeny, Staphylococcal Infections, Staphylococcus aureus, Virulence, Drug Resistance, Bacterial, Methicillin-Resistant Staphylococcus aureus, Multilocus Sequence Typing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review